Forensic Drug Abuse Advisor (FDAA) is the only monthly newsletter written for forensic scientists with a specific interest in problems related to drug abuse. It contains accounts of the most up-to-date, latest breaking scientific issues relating to drug testing and drug abuse. FDAA also offers ACCENT® CE credits.

FDAA contains no advertising and has no political affiliations. Our writers objectively report on the newest discoveries about the pathology and toxicology of drug abuse. There is no better source for unbiased information about drug testing and the medical consequences of drug abuse, including information about many drugs that you might not have suspected were abused.

You will save precious time when you read FDAA. We screen and review the hundreds of new articles published and read at meetings each month. Then we brief you on those we consider most important, and we explain why they are important. Reference citations are included for our readers who want to locate and read the entire research paper. Our areas of coverage include:

The latest developments in workplace drug testing: hair, urine, sweat, etc.

The latest regulations for federally mandated drug-testing programs

The latest in pre-employment testing and on-site testing

The latest developments in forensic toxicology

The most relevant discoveries in forensic pathology

Forensic Drug Abuse Advisor is now in its 21st year of publication and is the most widely read and respected newsletter in the field of drug abuse. Our editor, Steven B. Karch, M.D., is the author of Karch’s Pathology of Drug Abuse, A Brief History of Cocaine, The Consumer’s Guide to Herbal Medicine, and A History of Cocaine: The Mystery of Coca Java & the Kew Plant. He is also Editor-in-Chief of the Drug Abuse Handbook.

Give FDAA a try! You will quickly find that FDAA is the perfect supplement to increase your knowledge about what is going on in the field of drug abuse. It will keep you current and “in the know.” Our satisfied subscribers have told us so.

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Association for Clinical Chemistry (AACC) and the Forensic Drug Abuse Advisor. The AACC is accredited by the ACCME to provide continuing medical education for physicians. The AACC designates this continuing medical education activity for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The AACC also designates this activity for a maximum of 13.0 ACCENT® credit hours. AACC is an approved provider of continuing education for clinical laboratory scientists licensed in, but not limited to, the states of California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, and West Virginia.